Article Sidebar
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Salivary cortisol levels and temporomandibular disorders – A systematic review and meta-analysis of 13 case-control studies
Abstract
Purpose: To compare salivary cortisol levels between patients with temporomandibular disorders (TMD) and healthy controls.
Methods: Pubmed, EMBASE, Web of Science and PsycINFO databases were employed to screen for the included studies. RevMan 5.3 software and RStudio software were used for meta-analysis, while a random-effect model was selected to synthesize the effect with the mean difference (MD).
Results: Thirteen studies were eligible and a total of 504 TMD patients and 410 controls were included. The pooled MD of salivary cortisol levels in TMD patients compared to controls was 0.05 (95 %CI = 0.01 - 0.09, p = 0.02), indicating a significantly higher level of salivary cortisol in TMD patients than in the controls. Subgroup analysis suggested studies published later than 2014 showed significant increase of salivary cortisol level in TMD patients when compared to controls (MD = 0.07, 95 % CI = 0.01-0.13, p = 0.03). Besides, high-quality studies presented significant differences with regard to the cortisol level in saliva among individuals with or without TMD (MD = 0.04, 95 %CI = 0.03-0.05, p < 0.01). However, the instability of the results showed by the sensitivity analysis was a hindrance to reaching a definitive conclusion.
Conclusion: The findings of this study indicate that salivary cortisol level in TMD patients is significantly higher than in controls. Consequently, supportive psychological treatment is recommended to prevent TMD patients from mood disorders. More high-quality studies are, however, needed to confirm the relationship, considering the high degree of heterogeneity among the studies.
